Clinical Trial Update: Efficacy and Safety of Vedolizumab in Biologic-naïve Korean Patients With Moderate to Severe Inflammatory Bowel Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vedolizumab in biologic-naïve Korean patients with moderate to severe inflammatory bowel disease (Crohn's disease and ulcerative coliti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Yonsei University | Conditions: Crohn's Disease and Ulcerative Colitis | Phase 3 | Status: UNKNOWN